Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shahela Mahammad"'
Autor:
Myrna Hurtado, Umesh T. Sankpal, Aboubacar Kaba, Shahela Mahammad, Jaya Chhabra, Deondra T. Brown, Raj K. Gurung, Alvin A. Holder, Jamboor K. Vishwanatha, Riyaz Basha
Publikováno v:
Cellular Physiology and Biochemistry, Vol 51, Iss 4, Pp 1894-1907 (2018)
Background/Aims: Targeting survivin, an anti-apoptotic protein and mitotic regulator, is considered as an effective therapeutic option for pancreatic cancer (PaCa). Tolfenamic acid (TA) showed anti-cancer activity in pre-clinical studies. A recent di
Externí odkaz:
https://doaj.org/article/969788d246ee461c8f63fba115110c42
Autor:
Jamboor K. Vishwanatha, Riyaz Basha, Umesh T. Sankpal, Aboubacar Kaba, Deondra T. Brown, Shahela Mahammad, Raj K. Gurung, Alvin A. Holder, Myrna Hurtado, Jaya Chhabra
Publikováno v:
Cellular Physiology and Biochemistry, Vol 51, Iss 4, Pp 1894-1907 (2018)
Background/Aims: Targeting survivin, an anti-apoptotic protein and mitotic regulator, is considered as an effective therapeutic option for pancreatic cancer (PaCa). Tolfenamic acid (TA) showed anti-cancer activity in pre-clinical studies. A recent di
Autor:
Umesh T. Sankpal, Jaya Chhabra, Raj K. Gurung, Shahela Mahammad, Myrna Hurtado, Riyaz Basha, Alvin A. Holder, Deondra K. Brown
Publikováno v:
Cancer Research. 78:5804-5804
Despite advances in research, pancreatic cancer (PC) remains one of the most lethal malignancies. The five-year survival rate is 8% and standard treatment options often cause high toxicity. Thus, there is a pressing need for identifying less toxic ye
Autor:
Umesh T. Sankpal, Riyaz Basha, Myrna Hurtado, Alvin A. Holder, Aboubacar Kaba, Jamboor K. Vishwanatha, Shahela Mahammad
Publikováno v:
Cancer Research. 77:10-10
Pancreatic cancer is one of the most fatal malignancies due to its poor prognosis. With current standard treatment options, the overall 5 year survival rate is about 16% and these treatment plans often cause high toxicity. Therefore, there is an urge